U&I Corporation (056090) - Net Assets

Latest as of March 2026: ₩94.87 Billion KRW ≈ $64.29 Million USD

Based on the latest financial reports, U&I Corporation (056090) has net assets worth ₩94.87 Billion KRW (≈ $64.29 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩126.07 Billion ≈ $85.44 Million USD) and total liabilities (₩31.20 Billion ≈ $21.15 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore U&I Corporation balance sheet assets for the complete picture of this company's asset base.

Key Net Assets Metrics

Metric Value
Current Net Assets ₩94.87 Billion
% of Total Assets 75.25%
Annual Growth Rate 4.12%
5-Year Change 229.83%
10-Year Change 59.39%
Growth Volatility 36.64

U&I Corporation - Net Assets Trend (2015–2025)

This chart illustrates how U&I Corporation's net assets have evolved over time, based on quarterly financial data. Check U&I Corporation tangible equity quality to evaluate the tangible quality of the company's equity base.

Annual Net Assets for U&I Corporation (2015–2025)

The table below shows the annual net assets of U&I Corporation from 2015 to 2025. For live valuation and market cap data, see how much is U&I Corporation worth.

Year Net Assets Change
2025-12-31 ₩94.15 Billion
≈ $63.80 Million
+8.51%
2024-12-31 ₩86.77 Billion
≈ $58.80 Million
+44.85%
2023-12-31 ₩59.90 Billion
≈ $40.59 Million
+3.85%
2022-12-31 ₩57.68 Billion
≈ $39.09 Million
+102.07%
2021-12-31 ₩28.54 Billion
≈ $19.34 Million
+5.39%
2020-12-31 ₩27.09 Billion
≈ $18.36 Million
-28.70%
2019-12-31 ₩37.99 Billion
≈ $25.74 Million
-3.09%
2018-12-31 ₩39.20 Billion
≈ $26.57 Million
-27.80%
2017-12-31 ₩54.29 Billion
≈ $36.79 Million
-8.08%
2016-12-31 ₩59.07 Billion
≈ $40.03 Million
-6.01%
2015-12-31 ₩62.85 Billion
≈ $42.59 Million
--

Equity Component Analysis

This analysis shows how different components contribute to U&I Corporation's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 1272.9% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2025)

Component Amount Percentage
Other Components ₩144.87 Billion 154.11%
Total Equity ₩94.00 Billion 100.00%

U&I Corporation Competitors by Market Cap

The table below lists competitors of U&I Corporation ranked by their market capitalization.

Company Market Cap
IG Group Holdings PLC
LSE:IGG
$72.52 Million
CombinedX AB
ST:CX
$72.53 Million
Sports Entertainment Group Ltd
AU:SEG
$72.54 Million
Prozone Realty Limited
NSE:PROZONER
$72.58 Million
Metrofile
JSE:MFL
$72.47 Million
Ribbon Acquisition Corp Unit
NASDAQ:RIBBU
$72.46 Million
Algoltek Inc
TWO:6684
$72.44 Million
Airtasker Ltd
AU:ART
$72.43 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in U&I Corporation's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from 87,164,826,200 to 94,003,065,980, a change of 6,838,239,780 (7.8%).
  • Net income of 6,507,511,650 contributed positively to equity growth.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income ₩6.51 Billion +6.92%
Other Changes ₩330.73 Million +0.35%
Total Change ₩- 7.85%

Book Value vs Market Value Analysis

This analysis compares U&I Corporation's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 1.14x
  • The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
  • The price-to-book ratio has increased from 0.66x to 1.14x over the analyzed period, suggesting growing market confidence.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2016-12-31 ₩1560.83 ₩1036.00 x
2017-12-31 ₩1432.77 ₩1036.00 x
2018-12-31 ₩1027.02 ₩1036.00 x
2019-12-31 ₩992.37 ₩1036.00 x
2020-12-31 ₩674.08 ₩1036.00 x
2021-12-31 ₩619.82 ₩1036.00 x
2022-12-31 ₩731.55 ₩1036.00 x
2023-12-31 ₩763.05 ₩1036.00 x
2024-12-31 ₩844.14 ₩1036.00 x
2025-12-31 ₩910.36 ₩1036.00 x

Capital Efficiency Dashboard

This dashboard shows how efficiently U&I Corporation utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 6.92%
  • The company has moderate efficiency in generating returns from equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 13.78%
  • • Asset Turnover: 0.41x
  • • Equity Multiplier: 1.22x
  • Recent ROE (6.92%) is above the historical average (-13.14%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2015 -1.29% -5.56% 0.19x 1.23x ₩-7.10 Billion
2016 -3.52% -17.77% 0.18x 1.12x ₩-7.98 Billion
2017 -12.06% -49.23% 0.17x 1.46x ₩-11.97 Billion
2018 -37.55% -46.45% 0.42x 1.91x ₩-18.64 Billion
2019 -4.98% -5.43% 0.49x 1.87x ₩-5.69 Billion
2020 -45.35% -44.22% 0.43x 2.38x ₩-14.99 Billion
2021 -17.41% -13.06% 0.51x 2.63x ₩-7.82 Billion
2022 -32.13% -45.03% 0.29x 2.45x ₩-24.31 Billion
2023 2.71% 4.66% 0.44x 1.31x ₩-4.39 Billion
2024 0.07% 0.17% 0.32x 1.23x ₩-8.66 Billion
2025 6.92% 13.78% 0.41x 1.22x ₩-2.89 Billion

Industry Comparison

This section compares U&I Corporation's net assets metrics with peer companies in the Medical Devices industry.

Industry Context

  • Industry: Medical Devices
  • Average net assets among peers: $118,775,771,486
  • Average return on equity (ROE) among peers: 15.43%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
U&I Corporation (056090) ₩94.87 Billion -1.29% 0.33x $72.50 Million
Shinhung (004080) $106.86 Billion 7.92% 0.32x $88.38 Million
HansBiomed Corporation (042520) $24.04 Billion 10.48% 0.13x $225.75 Million
JVM Co. Ltd (054950) $158.12 Billion 9.96% 0.47x $170.55 Million
Huvitz Co. Ltd (065510) $78.68 Billion 3.95% 0.79x $53.08 Million
Vieworks Co. Ltd (100120) $84.60 Billion 18.79% 0.15x $138.92 Million
Corentec Co Ltd (104540) $60.18 Billion 0.77% 0.59x $33.79 Million
Hironic Co. Ltd (149980) $58.67 Billion 5.00% 0.15x $44.36 Million
Humasis Co. Ltd (205470) $346.73 Billion 52.67% 0.35x $164.48 Million
NH SPAC 2 (206640) $151.09 Billion 29.36% 0.27x $161.43 Million

About U&I Corporation

KQ:056090 Korea Medical Devices
Market Cap
$72.50 Million
₩106.98 Billion KRW
Market Cap Rank
#20474 Global
#1080 in Korea
Share Price
₩1036.00
Change (1 day)
-3.09%
52-Week Range
₩1025.00 - ₩1069.00
All Time High
₩1069.00
About

CG MedTech Co.,Ltd. researches, develops, manufactures, and sale of orthopedic medical devices in the healthcare service market. The company offers headless screws, cortex screws, and K-wires and pin; Aspiron and Maxima anterior cervical plate systems for use in anterior interbody screw/plate fixation of the cervical spine; ANAX OCT spinal system, a device for spinal surgery; Velofix PEEK SA cerv… Read more